- Published at
- by gurufocus.com
positive
positive
Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints | BSX Stock News
Boston Scientific (BSX) reports positive 12-month results from the second phase of the ADVANTAGE AF trial for the FARAPULSEâ„¢ Pulsed Field Ablation System